X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4679) 4679
Book / eBook (20) 20
Magazine Article (12) 12
Book Chapter (7) 7
Conference Proceeding (5) 5
Web Resource (5) 5
Dissertation (4) 4
Newsletter (2) 2
Journal / eJournal (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3490) 3490
anticarcinogenic agents - therapeutic use (3453) 3453
animals (2602) 2602
oncology (1641) 1641
female (1573) 1573
anticarcinogenic agents - pharmacology (1572) 1572
male (1472) 1472
cancer (1298) 1298
chemoprevention (1133) 1133
mice (1035) 1035
prevention (902) 902
neoplasms - prevention & control (776) 776
rats (768) 768
apoptosis (717) 717
pharmacology & pharmacy (575) 575
anticarcinogenic agents - administration & dosage (487) 487
middle aged (475) 475
apoptosis - drug effects (470) 470
carcinogenesis (462) 462
breast neoplasms - prevention & control (455) 455
risk factors (452) 452
cell line, tumor (411) 411
aged (384) 384
biochemistry & molecular biology (382) 382
risk (365) 365
inhibition (363) 363
diet (352) 352
adult (348) 348
health aspects (341) 341
nutrition & dietetics (341) 341
clinical trials as topic (337) 337
expression (336) 336
cell proliferation - drug effects (331) 331
research (328) 328
breast-cancer (326) 326
care and treatment (324) 324
in-vitro (306) 306
breast cancer (304) 304
tumors (302) 302
disease models, animal (296) 296
dose-response relationship, drug (290) 290
neoplasms - drug therapy (289) 289
tamoxifen - therapeutic use (289) 289
colonic neoplasms - prevention & control (288) 288
anticarcinogenic agents - chemistry (284) 284
anticarcinogenic agents - adverse effects (283) 283
antioxidants - therapeutic use (283) 283
carcinogens (281) 281
nf-kappa-b (277) 277
prostatic neoplasms - prevention & control (272) 272
oxidative stress (259) 259
lung neoplasms - prevention & control (258) 258
colorectal neoplasms - prevention & control (255) 255
skin neoplasms - prevention & control (248) 248
analysis (247) 247
antineoplastic agents - therapeutic use (246) 246
antioxidants (241) 241
colorectal cancer (239) 239
growth (239) 239
toxicology (234) 234
anti-inflammatory agents, non-steroidal - therapeutic use (230) 230
plant extracts - therapeutic use (230) 230
treatment outcome (224) 224
signal transduction - drug effects (221) 221
colorectal-cancer (215) 215
phytotherapy (215) 215
cells (214) 214
prostate cancer (214) 214
rats, sprague-dawley (210) 210
chemotherapy (208) 208
prostate-cancer (199) 199
chemistry, medicinal (198) 198
induction (196) 196
antioxidants - pharmacology (193) 193
tamoxifen (191) 191
plant extracts - pharmacology (190) 190
time factors (189) 189
carcinogens - toxicity (182) 182
dietary supplements (182) 182
green tea (179) 179
catechin - analogs & derivatives (177) 177
beta-carotene (174) 174
breast neoplasms - drug therapy (172) 172
cell biology (171) 171
gene-expression (171) 171
signal transduction (171) 171
cell division - drug effects (170) 170
activation (168) 168
rats, wistar (168) 168
colon cancer (167) 167
polyphenols (167) 167
proteins (167) 167
rodents (165) 165
tumor cells, cultured (165) 165
aberrant crypt foci (162) 162
cancer prevention (162) 162
inflammation (161) 161
rats, inbred f344 (160) 160
carotenoids - therapeutic use (157) 157
nonsteroidal antiinflammatory drugs (156) 156
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4610) 4610
French (32) 32
Russian (24) 24
German (22) 22
Japanese (20) 20
Spanish (15) 15
Chinese (9) 9
Polish (6) 6
Italian (5) 5
Czech (3) 3
Hebrew (3) 3
Hungarian (3) 3
Portuguese (3) 3
Dutch (2) 2
Slovak (2) 2
Korean (1) 1
Norwegian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 496 - 503
Summary In March, 2010, a group of breast cancer experts met to develop a consensus statement on breast cancer prevention, with a focus on medical and therapeutic interventions... 
Hematology, Oncology and Palliative Medicine | ZOLEDRONIC ACID | SURGICAL ADJUVANT BREAST | ONCOLOGY | STATIN USE | LOW-DOSE TAMOXIFEN | RANDOMIZED-TRIAL | FOLLOW-UP | RISK | BOWEL PROJECT | POSTMENOPAUSAL WOMEN | GENOME-WIDE ASSOCIATION | Thiophenes - therapeutic use | Metformin - therapeutic use | Raloxifene Hydrochloride - therapeutic use | Humans | Selective Estrogen Receptor Modulators - adverse effects | Tetrahydronaphthalenes - therapeutic use | Pyrrolidines - therapeutic use | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Estrogen Receptor Modulators - therapeutic use | Retinoids - therapeutic use | Selective Estrogen Receptor Modulators - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Female | Aromatase Inhibitors - therapeutic use | Estrogen Receptor Modulators - adverse effects | Anticarcinogenic Agents - therapeutic use | Triazoles - therapeutic use | Premenopause | Anastrozole | Consensus Development Conferences as Topic | Breast Neoplasms - prevention & control | Fenretinide - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Piperidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Tamoxifen - therapeutic use | Androstadienes - therapeutic use | Expert Testimony | Norpregnenes - therapeutic use | Nitriles - therapeutic use | COX-2 inhibitors | Care and treatment | Aspirin | Oncology, Experimental | Menopause | Phosphonates | Breast cancer | Retinoids | Research | Tamoxifen | Prevention | Analysis | Health aspects | Cancer
Journal Article
2006, ISBN 9780470012949, xvii, 350 p., [8] p. of plates
Book
International journal of cancer, ISSN 1097-0215, 2008, Volume 123, Issue 5, pp. 983 - 990
... of NSAIDs, especially on colorectal cancer. A promising strategy to enhance the cancer preventive efficacy of statins and NSAIDs is to use them in combination, which may produce synergy and lower the dose required for each agent... 
cancer chemoprevention | statins | NSAIDs | Cancer chemoprevention | Statins | CELECOXIB INDUCES APOPTOSIS | HUMAN LUNG-CANCER | SELECTIVE COX-2 INHIBITORS | PREVENT COLORECTAL ADENOMAS | COLON-CANCER | ONCOLOGY | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | CHOLESTEROL-LOWERING DRUGS | FAMILIAL ADENOMATOUS POLYPOSIS | NF-KAPPA-B | ENDOTHELIAL GROWTH-FACTOR | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Simvastatin - therapeutic use | Meta-Analysis as Topic | Pyrazoles - therapeutic use | Heptanoic Acids - therapeutic use | Humans | Neoplasms - prevention & control | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Fatty Acids, Monounsaturated - therapeutic use | Anticarcinogenic Agents - administration & dosage | Aspirin - therapeutic use | Drug Therapy, Combination | Pyrroles - therapeutic use | Anticarcinogenic Agents - pharmacology | Pravastatin - therapeutic use | Anticarcinogenic Agents - therapeutic use | Pyridines - therapeutic use | Lovastatin - therapeutic use | Drug Administration Schedule | Colorectal Neoplasms - prevention & control | Celecoxib | Sulindac - therapeutic use | Evidence-Based Medicine | Randomized Controlled Trials as Topic | Drug Synergism | Atorvastatin Calcium | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Indoles - therapeutic use | Index Medicus
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2016, Volume 133, Issue 11, pp. 1104 - 1114
.... Therapeutic advances, despite improving longevity, have increased the overlap between these diseases, with millions of cancer survivors now at risk of developing CVD... 
Cardiology | Cardiovascular diseases | Risk factors | Clinical oncology | risk factors | METABOLIC SYNDROME | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | cardiovascular diseases | ALCOHOL-CONSUMPTION | cardiology | BREAST-CANCER | COLORECTAL-CANCER | IGF-BINDING PROTEIN-3 | BODY-MASS INDEX | PERIPHERAL VASCULAR DISEASE | PHYSICAL-ACTIVITY | clinical oncology | GROWTH-FACTOR | RENAL-CELL CANCER | United States - epidemiology | Neoplasms - etiology | Age Factors | Oxidative Stress | Diet - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Neoplasms - prevention & control | Motor Activity | Hyperlipidemias - epidemiology | Cardiovascular Diseases - epidemiology | Adult | Female | Hyperinsulinism - epidemiology | Hypertension - epidemiology | Anticarcinogenic Agents - therapeutic use | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Comorbidity | Risk Factors | Inflammation - epidemiology | Antihypertensive Agents - therapeutic use | Alcohol Drinking - adverse effects | Antihypertensive Agents - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Smoking - epidemiology | Diabetes Mellitus - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Obesity - epidemiology | Aged | Hypoglycemic Agents - adverse effects | Neoplasms - epidemiology | Epidemiology | Analysis | Cancer | Index Medicus | Abridged Index Medicus | cardiovascular disease risk factors | cardio-oncology
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 2007, Volume 14, Issue 3, pp. 315 - 338
Journal Article
Pharmacological reviews, ISSN 1521-0081, 2012, Volume 64, Issue 1, pp. 102 - 146
Journal Article
Journal Article
Journal Article